Publications by authors named "Vishala Neppalli"

Claim this Profile
O
Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study.
Pallawi Torka, Othman S Akhtar, Nishitha M Reddy, Bora E Baysal, Angela Kader, Vishala Neppalli

Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple painful ulcerated lesions in a 73-year-old patient.
Vim S Mutalik, Vishala Neppalli, Catherine Dale, Carla Penner

Oral Surg Oral Med Oral Pathol Oral Radiol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered T Follicular Helper Cell Subsets and Function in Chronic Lymphocytic Leukemia.
Xun Wu, J Ernesto Fajardo-Despaigne, Christine Zhang, Vishala Neppalli, Versha Banerji

Front Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Sequencing Delineates Clonal Origins and Informs Therapeutic Strategies in Acute Lymphoblastic Leukemia and Histiocytic Sarcoma.
Gregory W Roloff, Jeffrey I Baron, Vishala T Neppalli, Sheila Sait, Elizabeth A Griffiths

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity.
George L Chen, Theresa Hahn, Gregory E Wilding, Adrienne Groman, Alan Hutson, Vishala Neppalli

Biol Blood Marrow Transplant· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiological imaging and bone marrow biopsy in staging of cutaneous B-cell lymphoma.
Pankit Vachhani, Vishala T Neppalli, Christopher J Cancino, Paul Bogner, Charles L Roche

Br J Haematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019.
William G Wierda, John C Byrd, Jeremy S Abramson, Syed F Bilgrami, Greg Bociek, Vishala T Neppalli

J Natl Compr Canc Netw· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
All--retinoic-acid and arsenic trioxide induced remission in promyelocytic blast crisis.
Teresa A Colvin, Pankit Vachhani, Sheila Sait, Vishala Neppalli, Eunice S Wang

Leuk Res Rep· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Trial of Rituximab Combined With Pegfilgrastim in Patients With Indolent B-cell Non-Hodgkin Lymphoma.
Pallawi Torka, Priyank Patel, Wei Tan, Gregory Wilding, Seema A Bhat, Vishala Neppalli

Clin Lymphoma Myeloma Leuk· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2018.
Shaji K Kumar, Natalie S Callander, Melissa Alsina, Djordje Atanackovic, J Sybil Biermann, Vishala T Neppalli

J Natl Compr Canc Netw· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAFRO syndrome: A case report and review of the literature.
Tieying Hou, Jaspreet Dhillon, Wenbin Xiao, Elaine S Jaffe, Amy M Sands, Vishala Neppalli

Hum Pathol (N Y)· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaplastic Multiple Myeloma: An Aggressive Variant With a Poor Response to Novel Therapies.
Nischala Ammannagari, Kimberly Celotto, Vishala Neppalli, Kelvin Lee, Sarah A Holstein

Clin Lymphoma Myeloma Leuk· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014.
Jonathan R Fromm, Damian J Tagliente, Aaron C Shaver, Vishala Neppalli, Fiona E Craig

Cytometry B Clin Cytom· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo.
Natalie M Czuczman, Matthew J Barth, Juan Gu, Vishala Neppalli, Cory Mavis

Blood· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remarkable Response to Methylprednisolone in a Multiple Myeloma Patient with Nodal Disease Refractory to High-Dose Chemotherapy.
Kimberly Celotto, Vishala Neppalli, Sarah Holstein

Cureus· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapy.
Venkata K Pokuri, Bo Xu, Vishala Neppalli, Jan Czyzyk, Farid Berenji

Ann Hematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009.
Sam M Mbulaiteye, Sheeja T Pullarkat, Bharat N Nathwani, Lawrence M Weiss, Nagesh Rao, Vishala Neppalli

APMIS· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies.
Edmund C Lee, Michael Fitzgerald, Bret Bannerman, Jill Donelan, Kristen Bano, Vishala T Neppalli

Clin Cancer Res· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappraisal of the provisional entity primary cutaneous CD4+ small/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature.
Christian L Baum, Brian K Link, Vishala T Neppalli, Brian L Swick, Vincent Liu

J Am Acad Dermatol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunostaining to identify molecular subtypes of diffuse large B-cell lymphoma in a population-based epidemiologic study in the pre-rituximab era.
Lindsay M Morton, James R Cerhan, Patricia Hartge, Mohammad A Vasef, Vishala T Neppalli

Int J Mol Epidemiol Genet· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dextran removal by plasmapheresis in a kidney-pancreas transplant recipient with dextran 40-induced osmotic nephrosis.
Aash P Bhatt, Vishala T Neppalli, Elizabeth A Kelley, Annette J Schlueter, Christie P Thomas

Am J Kidney Dis· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6 and MYC collaborate in plasma cell tumor formation in mice.
Sebastian Rutsch, Vishala T Neppalli, Dong-Mi Shin, Wendy DuBois, Herbert C Morse

Blood· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal nerve deficiency in chronic childhood constipation: a postmigration defect?
Gwen Wendelschafer-Crabb, Vishala Neppalli, Jose Jessurun, James Hodges, Karl Vance

J Pediatr Surg· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Javeed Iqbal, Vishala T Neppalli, George Wright, Bhavana J Dave, Douglas E Horsman

J Clin Oncol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis